Noninvasive 40Hz light-and-sound brain stimulation aimed at Alzheimer’s changes with a female focus

Noninvasive Neurostimulation to Reduce Pathology in a Female Mouse Model of Alzheimer's Disease

NIH-funded research Veterans Health Administration · NIH-11092943

Seeing if gentle 40Hz light-and-sound stimulation can reduce Alzheimer’s-related brain changes that may be especially important for women.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Decatur, UNITED STATES)
Project IDNIH-11092943 on NIH RePORTER

What this research studies

Researchers will use noninvasive 40Hz "gamma flicker" light and sound to stimulate brain activity in female mouse models of Alzheimer’s disease. They will measure effects on brain immune cells (microglia), inflammatory signals, and key brain chemicals such as dopamine, norepinephrine, and BDNF that support memory. The team will target early, prodromal stages before neuron loss to see whether pathology and memory problems can be reduced. Results in mice would help decide if similar, women-focused human trials should be pursued.

Who could benefit from this research

Good fit: The most relevant human candidates for future trials would be women with early or prodromal Alzheimer's disease or older women at elevated risk for Alzheimer’s.

Not a fit: People with advanced Alzheimer’s disease or other types of dementia are less likely to benefit from early-stage treatments aimed at preventing or reversing early pathology.

Why it matters

Potential benefit: If successful, this approach could point to a noninvasive therapy to reduce Alzheimer’s pathology and help preserve memory, particularly for women.

How similar studies have performed: Related 40Hz "gamma" stimulation reduced amyloid and engaged microglia in prior mouse studies and has been explored in small early human pilot projects, but evidence in people is still preliminary.

Where this research is happening

Decatur, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.